Public Profile

Vericel Corporation

Vericel Corporation, a leading player in the regenerative medicine industry, is headquartered in the United States. Founded in 1989, the company has made significant strides in developing innovative cell-based therapies, particularly for patients with severe skin injuries and cartilage damage. Vericel's core products, including Epicel® and MACI®, are distinguished by their ability to harness the body’s own cells to promote healing, setting them apart in the competitive landscape of advanced therapeutics. With a strong presence in the US and expanding operations in key international markets, Vericel has established itself as a pioneer in the field. The company’s commitment to research and development has led to notable achievements, including FDA approvals that underscore its market position. Vericel continues to drive advancements in regenerative medicine, aiming to improve patient outcomes and redefine treatment paradigms.

DitchCarbon Score

How does Vericel Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Vericel Corporation's score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

Vericel Corporation's reported carbon emissions

Vericel Corporation, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives related to climate commitments. Without specific emissions figures or defined reduction strategies, it is challenging to assess their environmental impact or progress in addressing climate change. As the company operates within the biotechnology sector, it is essential for them to consider industry standards and best practices in sustainability to enhance their climate commitments moving forward.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vericel Corporation's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Vericel Corporation is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vericel Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Orthofix

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Osiris Therapeutics, Inc.

US
Health and social work services (85)
Updated 5 days ago
DitchCarbon Score

Surgalign Holdings, Inc.

US
Health and social work services (85)
Updated 2 days ago

NuVasive, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago
DitchCarbon Score

Musculoskeletal Transplant Foundation

US
Health and social work services (85)
Updated 3 days ago

Mallinckrodt plc

IE
Chemicals nec
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers